Pharmaceutical - Women's Health


Current filters:

Women's Health

Popular Filters

26 to 50 of 84 results

Contraceptive benefits outweigh risks of blood clots, say EMA

Contraceptive benefits outweigh risks of blood clots, say EMA


The European Medical Agency’s Pharmacovigilance Risk Assessment Committee has decided that the benefits…

EuropePharmaceuticalRegulationWomen's Health

FDA approves Bayer’s Adempas; firm accelerates drug candidates

FDA approves Bayer’s Adempas; firm accelerates drug candidates


The US Food and Drug Administration late yesterday approved Adempas (riociguat), developed by German…

AdempasBayerCardio-vascularcopanlisibfinerenoneNorth AmericaOncologyPharmaceuticalRegulationResearchRespiratory and PulmonaryWomen's Health

US FDA backs Pfizer’s hot flashes drug Duavee

US FDA backs Pfizer’s hot flashes drug Duavee


Pfizer and partner Ligand Pharmaceuticals say that the US Food and Drug Administration has approved Duavee,…

bazedoxifeneDuaveeLigand PharmaceuticalsNorth AmericaPfizerPharmaceuticalRegulationWomen's Health

Phebra gains right to market Syntometrine in Australia

Phebra gains right to market Syntometrine in Australia


Phebra has signed an exclusive commercial agreement with UK-based pharmaceutical firm Alliance Pharma…

Alliance PharmaAsia-PacificLicensingPharmaceuticalSyntometrineWomen's Health

K-V Pharmaceutical emerges from bankruptcy with $375 million recapitalization


USA-based K-V Pharmaceutical, which filed for bankruptcy in August 2012, when it was embroiled in controversy…

FinancialK-V PharmaceuticalPharmaceuticalWomen's Health

Italy's Recordati to acquire Spanish drugmaker


In a second takeover deal this year, Italian drugmaker Recordati (RC: MI) says it has signed agreements…

CitrafleetGastro-intestinalsLab Casen FleetMergers & AcquisitionsPharmaceuticalRecordatiWomen's Health

Pharmacovigilance Risk Assessment Committee meeting highlights


The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) gave recommendations…

bromocriptineEuropeNumetaPharmaceuticalRegulationWomen's Health

Pharmaceutical patent sale of first-in-class compounds to treat women's health needs


IP Shakti, an early-stage seed fund for biomedical and life science innovations and the exclusive broker…

BezielleIP ShaktiLicensingMenerbaPatentsPharmaceuticalSealaWomen's Health

ObsEva gets funding and makes deal with Merck Serono


Geneva, Switzerland-based ObsEva says that it has closed a 32 million Swiss franc ($34.8 million) -A…

FinancialLicensingMerck KGaAMerck SeronoObsEvaPharmaceuticalWomen's Health

Actavis gains global rights for antifungal agent albaconazole


US generic drugs major Actavis (NYSE: ACT),which also has strong interests in women's health products,…

ActavisalbaconazoleGlobalLicensingPalau PharmaPharmaceuticalWomen's Health

BMG Pharma and Julphar in women's health licensing deal


Italian specialty drugmaker BMG Pharma and United Arab Emirates-based Julphar - Gulf Pharmaceutical Industries…

BMG GinoxilBMG PharmaJulpharLicensingPharmaceuticalRest of the WorldWomen's Health

Ligand enters global license deal for women's health product


Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

Noven's Brisdelle is first non-hormonal treatment for menopausal hot flashes to be approved by FDA


The US Food and Drug Administration on Friday (June 28) approved Noven Pharmaceuticals' Brisdelle (paroxetine)…

BrisdelleHisamitsu PharmaNorth AmericaNoven PharmaceuticalsparoxetinePharmaceuticalRegulationWomen's Health

Japan vaccines briefs: Gardasil and Cervarix; Daiichi Sankyo files NDA


The Japanese Ministry of Health, Labor and Welfare has decided to withdraw its recommendation for a vaccination…

Asia-PacificCervarixDaiichi SankyoGardasilGlaxoSmithKlineMerck & CoPharmaceuticalRegulationVaccinesWomen's Health

FDA approves Plan B One-Step emergency contraceptive for OTC use by women of child-bearing potential


The US Food and Drug Administration has approved the use of Plan B One-Step (levonorgestrel), from Israel-headquartered…

North AmericaPharmaceuticalPlan B One-StepRegulationReproductiveTeva Pharmaceutical IndustriesWomen's Health

Alliance Pharma buys expanded rights to Syntometrine from Novartis


UK specialty drugmaker Alliance Pharma (AIM: APH) says it has acquired all existing rights to Syntometrine…

Alliance PharmaMarkets & MarketingNovartisPharmaceuticalSyntometrineWomen's Health

Actavis confirms plan to acquire Warner Chilcott, in $8.5 billion deal


US generics major Actavis (NYSE: ACT) revealed today (May 20) that it has entered into a definitive agreement…

ActavisGenericsMergers & AcquisitionsPharmaceuticalWarner ChilcottWomen's Health

Bayer to acquire Conceptus for about $1.1 billion


German drugs and chemical major Bayer (BAYN: DE) has signed an agreement to acquire Conceptus (Nasdaq:…

BayerConceptusEssureMergers & AcquisitionsPharmaceuticalReproductiveWomen's Health

US federal judge tells FDA to lift age restrictions on morning-after pill


A US federal judge has ordered the Food and Drug Administration to lift age and other restrictions on…

LegalPharmaceuticalPlan BReproductiveTeva Pharmaceutical IndustriesWomen's Health

US FDA approves Teva's oral contraceptive Quartette


There was good news for Israeli drugmaker Teva Pharmaceutical Industries (NYSE: TEVA) when the US Food…

North AmericaPharmaceuticalQuartetteRegulationReproductiveTeva Pharmaceutical IndustriesWomen's Health

26 to 50 of 84 results

Back to top